highperformr logo

Cedilla Therapeutics's Overview

Total employees6
HeadquartersCambridge
Founded2018

Cedilla Therapeutics is a private biotechnology company pioneering a new dimension in precision oncology. They are focused on developing novel small molecule therapeutics that conditionally modulate protein stability. Their approach aims to harness the cell's natural protein degradation and stabilization machinery to selectively inhibit or degrade oncogenic drivers. This innovative strategy seeks to create powerful and highly selective medicines for cancers and other diseases with high unmet medical need, potentially addressing targets previously considered undruggable.

Where is Cedilla Therapeutics's Headquarters?

HQ Function

The Cambridge headquarters serves as the central hub for Cedilla's research and development activities, strategic operations, and corporate functions.

Notable Features:

Located in a modern life sciences complex, the facility likely includes state-of-the-art laboratory spaces for drug discovery and development, alongside collaborative office environments.

Work Culture:

As a research-driven biotech, the culture is likely dynamic, innovative, and science-focused, emphasizing collaboration and a commitment to tackling challenging diseases.

HQ Significance:

Its location in Cambridge provides access to a rich ecosystem of academic institutions, talent, and other biotech companies, fostering collaboration and innovation.

Values Reflected in HQ: The headquarters likely reflects Cedilla's commitment to cutting-edge science, innovation, and a focused approach to developing transformative therapies.

Location:

Cedilla Therapeutics is primarily based in the United States, with its research and development centered in its Cambridge, MA headquarters. While direct global offices are not prominent, its collaborations, clinical trial sites (as programs advance), and partnerships may extend internationally to leverage global expertise and patient populations in oncology.

Street Address:

200 Cambridgepark Drive, Suite 3000

City:

Cambridge

State/Province:

MA

Country:

USA

Cedilla Therapeutics's Global Presence

Buying Intent Signals for Cedilla Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Cedilla Therapeutics

As of April 2025, Cedilla Therapeutics' leadership includes:

Alexandra Glucksmann, Ph.D. - President & Chief Executive Officer
Justin Renz, J.D. - Chief Financial Officer & Chief Business Officer
Brian Jones, Ph.D. - Chief Scientific Officer
Chris Bowden, M.D. - Chief Medical Officer
Karen Tubridy, Pharm.D. - Chief Development Officer
Curtis Keith, Ph.D. - Chief Operating Officer

Investors of Cedilla Therapeutics

Cedilla Therapeutics has been backed by several prominent investors over the years, including:

Third Rock Ventures
Casdin Capital
RA Capital Management
Boxer Capital of Tavistock Group
Janus Henderson Investors
Woodline Partners LP
Soleus Capital
Logos Capital

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits0

Cedilla Therapeutics has strengthened its leadership team with key appointments, particularly enhancing its development and financial strategy capabilities.

New Appointments:

Karen Tubridy, Pharm.D., Karen Tubridy joined Cedilla as Chief Development Officer to lead and oversee the clinical development of Cedilla's therapeutic candidates.
Justin Renz, J.D., Justin Renz was appointed CFO and CBO, bringing significant financial and corporate strategy expertise to Cedilla.

Technology (Tech Stack) used by Cedilla Therapeutics

Discover the tools Cedilla Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Cedilla Therapeutics Email Formats and Examples

Cedilla Therapeutics likely utilizes common corporate email formats. The most probable format is [first_initial][last]@cedillatx.com.

[first_initial][last]@cedillatx.com

Format

aglucksmann@cedillatx.com

Example

80%

Success rate

News and media

Cedilla Therapeutics Website (Press Release)October 26, 2023

Cedilla Therapeutics to Present at Upcoming Investor and Scientific Conferences in November

Cedilla Therapeutics announced its participation and presentations at the Stifel 2023 Healthcare Conference and the 35th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, highlighting its ongoing work in developing novel cancer therapies....more

Cedilla Therapeutics Website (Press Release)May 1, 2023

Cedilla Therapeutics Appoints Karen Tubridy, Pharm.D., as Chief Development Officer

Cedilla Therapeutics announced the appointment of Karen Tubridy, Pharm.D., as Chief Development Officer. Dr. Tubridy brings over 20 years of experience in global drug development, with a focus on oncology....more

Cedilla Therapeutics Website (Press Release)April 17, 2023

Cedilla Therapeutics Presents Preclinical Data from Two Lead Programs Targeting TEAD and CDK2 at the AACR Annual Meeting 2023

Cedilla Therapeutics presented preclinical data for its TEAD inhibitor (CTX-4774) and CDK2 inhibitor (CTX-3223) at the American Association for Cancer Research (AACR) Annual Meeting 2023, showcasing their potential in oncology....more

Cedilla Therapeutics Website (Press Release)January 4, 2023

Cedilla Therapeutics Appoints Justin Renz as Chief Financial Officer and Chief Business Officer

Cedilla Therapeutics announced the appointment of Justin Renz, J.D., M.B.A., as chief financial officer (CFO) and chief business officer (CBO). Mr. Renz brings nearly 20 years of experience in healthcare finance, strategy, and business development....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Cedilla Therapeutics, are just a search away.